What is the current Price Target for the Vincerx Pharma Inc stock?

The average Vincerx Pharma Inc target price is $204.00. This is 518,984.00% higher than the current stock price. The highest price target is 534,251.15%, the lowest is 513,894.91%. 3 Analysts have issued a price target Vincerx Pharma Inc 2026 .

How high will the Vincerx Pharma Inc stock rise?

No reliable answer can be given as to how high the Vincerx Pharma Inc stock will rise. The performance of stocks, including the Vincerx Pharma Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Vincerx Pharma Inc stock today?

The performance of Vincerx Pharma Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Vincerx Pharma Inc stock fall?

The decline in Vincerx Pharma Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Vincerx Pharma Inc Forecast, price target & analysts

$0.04

1.75% yesterday

Nasdaq, Sep 12, 09:27 pm CET

ISIN

US92731L1061

Symbol

VINC

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Vincerx Pharma Inc Target price 2025 - Analyst rating & recommendation

Vincerx Pharma Inc Classifications & Recommendation:

Buy

86%

Hold

14%

Vincerx Pharma Inc Price Target

Target Price	$204.00
Price	$0.04
Potential	518,984.00% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target Vincerx Pharma Inc 2026 . The average Vincerx Pharma Inc target price is $204.00. This is 518,984.00% register free of charge higher than the current stock price. The highest price target is $210.00 534,251.15% register free of charge , the lowest is $202.00 513,894.91% register free of charge .
	A rating was issued by 7 analysts: 6 Analysts recommend Vincerx Pharma Inc to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Vincerx Pharma Inc stock has an average upside potential 2026 of 518,984.00% register free of charge . Most analysts recommend the Vincerx Pharma Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-15.85	-12.24
	57.97%	22.78%
P/E		0.00

3 Analysts have issued a Vincerx Pharma Inc forecast for earnings per share. The average Vincerx Pharma Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-15.85	57.97%
2025	$-12.24 22.78% Unlock
2026	$-0.58 95.26% Unlock

Current	0.00	99.69%
2025	0.00 100.00% Unlock

Vincerx Pharma Inc...

Current Vincerx Pharma Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Leerink Partners	Locked ➜ Locked	Locked	Oct 08 2024

Analyst Rating	Date
Locked Leerink Partners: Locked ➜ Locked	Oct 08 2024

Discover more stocks with a high price target

Novo Nordisk 46.43%

BioNTech SE - ADR 43.92%

Deutsche Telekom 29.16%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now